ALI DENKTAS to Risk Assessment
This is a "connection" page, showing publications ALI DENKTAS has written about Risk Assessment.
Connection Strength
0.188
-
Coronary Physiology Assessment for the Diagnosis and Treatment of Stable Ischemic Heart Disease. Curr Atheroscler Rep. 2016 10; 18(10):62.
Score: 0.066
-
Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry. JACC Cardiovasc Interv. 2008 Oct; 1(5):504-10.
Score: 0.038
-
Management of Acute Coronary Syndrome in Patients With Transcatheter Aortic Valve Replacement: A Review. Catheter Cardiovasc Interv. 2025 03; 105(4):959-969.
Score: 0.029
-
Temporal trends, outcomes, and predictors of mortality after pericardiocentesis in the United States. Catheter Cardiovasc Interv. 2020 02 15; 95(3):375-386.
Score: 0.020
-
Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2019 11 11; 12(21):2186-2194.
Score: 0.020
-
Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol. 2007 May 02; 117(3):365-9.
Score: 0.008
-
Safety and efficacy of cutting balloon angioplasty: the Mayo Clinic experience. J Invasive Cardiol. 2002 Dec; 14(12):720-4.
Score: 0.006